Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Tolcapone Alone and in Combination With Oxaliplatin in Patients With Relapsed or Refractory Neuroblastoma

NCT02630043 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT02630043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02630043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Tolcapone Alone and in Combination With Oxaliplatin in Patients With Relapsed or Refractory Neuroblastoma
Lead sponsor
Giselle Sholler
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2015
Completion date
July 31, 2019
Enrollment
5 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma